| License: Creative Commons Attribution 4.0 PDF - Published Version (7MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-585506
- DOI to cite this document:
- 10.5283/epub.58550
Abstract
Extracorporeal membrane oxygenation (ECMO) was established as a treatment for severe cardiac or respiratory disease. Intra-device clot formation is a common risk. This is based on complex coagulation phenomena which are not yet sufficiently understood. The objective was the development and validation of a methodology to capture the key properties of clots deposed in membrane lungs (MLs), such as ...

Owner only: item control page

Download Statistics